Neovascular Age-Related Macular Degeneration (Narmd), Monitoring the Effectiveness of a Stable Treatment: A Prospective Study

Abstract

This study aims to demonstrate the effectiveness of a stable treatment, with relevant and long-term results, in patients diagnosed with neovascular AMD. The data were collected by analyzing the best-corrected visual acuity (BCVA) and optical coherence tomography (OCT) images at the first visit and the last visit after two years of follow-up. This study compares the functional and structural visual results between patients who did not regularly follow their planned intravitreal anti-VEGF injection intervals with those who did. Currently, there are no studies in our country that certify the correct management of treatment for nAMD patients or optimal eye care services to support them. This is important for creating evidence and strategies for better treatment and monitoring of patients with advanced neovascular AMD. This study identifies the role of correctly adhering to treatment for maintaining optimal BCVA and the quality of life of people at risk of progression to late AMD. The group of patients with nAMD who did not adhere correctly to the planned intravitreal anti-VEGF injections had worse functional and structural results in BCVA and OCT. We recommend emphasizing the importance of maintaining continuity of care for neovascular AMD patients to achieve better results in BCVA and quality of life.

Received: 8 August 2024 / Accepted: 31 October 2024 / Published: 3 December 2024